Neurocrine Biosciences
NBIX
#1432
Rank
โ‚น1.017 T
Marketcap
โ‚น10,082
Share price
-0.86%
Change (1 day)
11.75%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : โ‚น66.76 B

According to Neurocrine Biosciences 's latest financial reports the company's total liabilities are โ‚น66.76 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Neurocrine Biosciences - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31โ‚น84.86 B55.17%
2022-12-31โ‚น54.68 B5.06%
2021-12-31โ‚น52.05 B17.17%
2020-12-31โ‚น44.42 B-6.72%
2019-12-31โ‚น47.62 B33.63%
2018-12-31โ‚น35.64 B25.31%
2017-12-31โ‚น28.44 B733.62%
2016-12-31โ‚น3.41 B2.02%
2015-12-31โ‚น3.34 B53.91%
2014-12-31โ‚น2.17 B2.61%
2013-12-31โ‚น2.11 B-7.06%
2012-12-31โ‚น2.27 B-44.98%
2011-12-31โ‚น4.14 B-26.14%
2010-12-31โ‚น5.60 B80.04%
2009-12-31โ‚น3.11 B-23.04%
2008-12-31โ‚น4.04 B-35.02%
2007-12-31โ‚น6.22 B87.6%
2006-12-31โ‚น3.32 B-20.68%
2005-12-31โ‚น4.18 B-15.12%
2004-12-31โ‚น4.93 B-34.01%
2003-12-31โ‚น7.47 B268.55%
2002-12-31โ‚น2.02 B16.87%
2001-12-31โ‚น1.73 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
โ‚น73.45 B 10.02%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น663.16 B 893.31%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น0.82 B-98.77%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น4.885 T 7,218.33%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น11.335 T 16,878.64%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น10.756 T 16,011.84%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น36.92 B-44.69%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น3.67 B-94.49%๐Ÿ‡บ๐Ÿ‡ธ USA